Vukmirovic, and M
Currently, there are other dual GIPR/GLP-1R agonists available, such as GLP-1R/GR (glucagon receptor), GLP-1R/AR (amylin receptor), and GLP-1R/NPYR (peptide YY binds to neuropeptide Y receptors) [36, 115] and even triple agonists that can activate GIPR to treat obesity and T2DM
doi:10.1097/CM9.0000000000002225 Dhar R, Singh S, Talwar D, Mohan M, Tripathi SK, Swarnakar R, et al
Studies have found it may suppress NF-kB activation, lowering inflammatory cytokine production independently of melanocortin receptors
Roux-en-Y gastric bypass and caloric restriction but not gut hormone-based treatments profoundly impact the hypothalamic transcriptome in obese rats